Arkolith/Insider Trading/TECH/Form 4

Kelderman Kim

Chief Executive Officer, DirectorBIO-TECHNE Corp (TECH) · full profile →Form 4 · filed Jan 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2025Sell(S)12K$77.19$906K41K
Jan 27, 2025Option exercise(M)13K$37.70$505K52K
Jan 27, 2025Sell(S)2K$77.95$129K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2025Option exercise(M)13K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-001237) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BIO-TECHNE Corp

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp